BamSEC and AlphaSense Join Forces
Learn More

Oyster Point Pharma Inc

Formerly NASDAQ: OYST
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 10-Q 2 pages Via Docusign [***] [***] Re: Discretionary Equity Award and Bonus Dear [ ]
12/34/56
EX-10.1
from 10-Q 11 pages Consulting Services Agreement
12/34/56
EX-10.17
from 10-K 11 pages Oyster Point Pharma, Inc. 2019 Equity Incentive Plan Performance Unit Agreement Notice of Performance Unit Grant
12/34/56
EX-10.2
from 10-Q 58 pages License and Collaboration Agreement
12/34/56
EX-10.1
from 8-K 8 pages Waiver and Amendment
12/34/56
EX-10.3
from 10-Q 6 pages Oyster Point Pharma, Inc. Rsu Award Grant Notice
12/34/56
EX-10.2
from 10-Q 10 pages Oyster Point Pharma, Inc. Stock Option Grant Notice
12/34/56
EX-10.1
from 10-Q 32 pages Oyster Point Pharma, Inc. 2021 Inducement Plan Adopted by the Board of Directors: July 30, 2021
12/34/56
EX-10.9
from 10-K 4 pages Oyster Point Pharma, Inc. Outside Director Compensation Policy
12/34/56
EX-10.11
from S-1/A 19 pages Certain Identified Information Has Been Omitted From This Document Because It Is Both Not Material and Would Be Competitively Harmful if Publicly Disclosed, and Has Been Marked With “[***]” to Indicate Where Omissions Have Been Made. Non-Exclusive Patent License Agreement
12/34/56
EX-10.4
from S-1/A 18 pages Oyster Point Pharma, Inc. 2019 Employee Stock Purchase Plan
12/34/56
EX-10.3
from S-1/A 46 pages Oyster Point Pharma, Inc. 2019 Equity Incentive Plan
12/34/56
EX-10.10
from S-1 6 pages Oyster Point Pharma, Inc. Executive Incentive Compensation Plan
12/34/56
EX-10.9
from S-1 5 pages Oyster Point Pharma, Inc. Outside Director Compensation Policy
12/34/56
EX-10.8
from S-1 12 pages Oyster Point Pharma, Inc. Change in Control and Severance Agreement
12/34/56
EX-10.7
from S-1 4 pages John Snisarenko August 2, 2019 [Personal Home Address] Dear John: On Behalf of Oyster Point Pharma, Inc. (The “Company”), I Am Pleased to Offer You the Position of Chief Commercial Officer. the Terms of This Offer Are as Follows
12/34/56
EX-10.6
from S-1 6 pages Daniel Lochner [Personal Address] Dear Daniel: On Behalf of Oyster Point Pharma, Inc. (The “Company”), I Am Pleased to Offer You the Position of Chief Financial Officer. the Terms of This Offer Are as Follows
12/34/56
EX-10.5
from S-1 4 pages Oyster Point Pharma, Inc. November 1, 2017
12/34/56
EX-10.2
from S-1 28 pages Oyster Point Pharma, Inc. 2016 Equity Incentive Plan
12/34/56
EX-10.1
from S-1 14 pages Oyster Point Pharma, Inc. Indemnification Agreement
12/34/56